# Split-Face Prospective Study Comparing Botox to Xeomin for the Treatment of Facial Wrinkles

> **NCT02122536** · NA · COMPLETED · sponsor: **YMD Eye and Face** · enrollment: 45 (actual)

## Conditions studied

- Facial Wrinkles

## Interventions

- **DRUG:** Xeomin to right side of face in half of the subjects; Xeomin to left side of face in the other half of subjects
- **DRUG:** Botox to right side of face in half of the subjects (randomized); Botox to the left side of the face in the other half of subjects

## Key facts

- **NCT ID:** NCT02122536
- **Lead sponsor:** YMD Eye and Face
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2012-11
- **Final completion:** 2013-11
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2014-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02122536

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02122536, "Split-Face Prospective Study Comparing Botox to Xeomin for the Treatment of Facial Wrinkles". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT02122536. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*